Compare Abeona Therapeutics Inc (ABEO) vs FuelCell Energy Inc (FCEL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs FuelCell Energy Inc — how do they compare? Abeona Therapeutics Inc trades at $6.74 (market cap $373.32M), while FuelCell Energy Inc trades at $23.07 (market cap $1.76B). The key difference: FuelCell Energy Inc is far larger — about 4.7× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, FuelCell Energy Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | FCEL | |
|---|---|---|
Market Cap | $373.32M | $1.76B |
Sector | Health | Industrials |
52-Week High | $7.23 | $36.01 |
52-Week Low | $4.17 | $3.92 |
Enterprise Value | $228.22M | $1.60B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
FCEL trades at $25.96, down 7.65% amid a $200 million stock offering announcement, yet maintains a bullish technical signal with support near $25. Revenue grew to $158.16M in 2025, but profitability remains challenged with a net income margin of -132.41%. Recent news highlights a 5 GW proposal pipeline, with 90% tied to data center power demand, and a $49 million EXIM financing boost for global expansion.
The outlook is speculative; growth potential from AI-driven data center deals and clean energy exports is offset by persistent losses, negative cash flow from operations, and dilution risk from equity offerings. Analyst consensus is mixed with a $20.13 price target, suggesting caution despite bullish technicals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About FuelCell Energy Inc
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.
Read more on FCEL →
